Medicare Launches Pilot Program to Evaluate CBD for Senior Health
New Federal Pilot Program Targets CBD Use in Medicare Patients The Trump administration has officially authorized a groundbreaking test program designed to assess the efficacy of cannabidiol (CBD) in managing chronic symptoms among Medicare beneficiaries. This initiative aims to determine if integrating the non-psychoactive cannabis compound into geriatric care can improve patient outcomes while simultaneously…